Clinical Interpretation of Indices of Quality of Glycemic Control and Glycemic Variability

Abstract The practicing physician is faced with the task of interpreting > 2 dozen indices of quality of glycemic control and glycemic variability. It would be desirable to have reference data from relevant patient populations (eg, patients with the same type of diabetes, duration of diabetes, therapeutic regimen, or glycated hemoglobin [HbA1c] levels). The physician can then select the appropriate reference set for interpretation of results for each patient. Institutions and clinics may wish to develop their own reference data. Results can be interpreted as excellent, good, fair, or poor, corresponding with quartiles of their distributions. Each index of glycemic control and variability can be given a numerical score in terms of its percentile within the selected reference population. One can then compute the mean and standard deviation of the percentile scores to obtain an integrated measure of the quality of glycemic control or variability. We calculated quartiles for measures of quality of glycemic control and variability. One can use the percent coefficient of variation (%CV) with criteria that apply irrespective of the HbA1c level as a general rule for interpretation of glycemic variability. For example, a %CV < 33.5% can be regarded as excellent, a %CV between 33.5% to 36.8% as good, a %CV between 36.8% to 40.6% as fair, and a %CV > 40.6% as poor. A graphical display can be used to make more accurate assessments for narrow HbA1c ranges, as the percentiles of the %CV can change systematically with HbA1c level or with mean glucose level.

[1]  Peter A Baghurst,et al.  Calculating the mean amplitude of glycemic excursion from continuous glucose monitoring data: an automated algorithm. , 2011, Diabetes technology & therapeutics.

[2]  Eckhard Salzsieder,et al.  The use of a computer program to calculate the mean amplitude of glycemic excursions. , 2011, Diabetes technology & therapeutics.

[3]  E. Kilpatrick Arguments for and against the Role of Glucose Variability in the Development of Diabetes Complications , 2009, Journal of diabetes science and technology.

[4]  Michael Brownlee,et al.  The Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes , 2007, Diabetes Care.

[5]  J. Krinsley,et al.  Glycemic variability: A strong independent predictor of mortality in critically ill patients* , 2008, Critical care medicine.

[6]  J. DeVries,et al.  A Decrease in Glucose Variability Does Not Reduce Cardiovascular Event Rates in Type 2 Diabetic Patients After Acute Myocardial Infarction , 2011, Diabetes Care.

[7]  F. Service,et al.  Characteristics of Glycemic Stability , 1980, Diabetes Care.

[8]  A. Rigby,et al.  The Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes , 2007, Diabetes Care.

[9]  Irl B Hirsch,et al.  Glycemic variability: it's not just about A1C anymore! , 2005, Diabetes technology & therapeutics.

[10]  Frits Holleman,et al.  Glucose variability; does it matter? , 2010, Endocrine reviews.

[11]  J. Levy,et al.  A method for assessing quality of control from glucose profiles , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[12]  M. Rewers,et al.  Glycaemic variability is associated with coronary artery calcium in men with Type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes study , 2010, Diabetic medicine : a journal of the British Diabetic Association.

[13]  Wojciech Fendler,et al.  GlyCulator: A Glycemic Variability Calculation Tool for Continuous Glucose Monitoring Data , 2011, Journal of diabetes science and technology.

[14]  Robert Cuddihy,et al.  Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis. , 2008, Diabetes technology & therapeutics.

[15]  Wójcicki Jm,et al.  J"-index. A new proposition of the assessment of current glucose control in diabetic patients. , 1995 .

[16]  Angelo J. Canty,et al.  A Genome-Wide Association Study Identifies a Novel Major Locus for Glycemic Control in Type 1 Diabetes, as Measured by Both A1C and Glucose , 2009, Diabetes.

[17]  David Rodbard,et al.  Responses to continuous glucose monitoring in subjects with type 1 diabetes using continuous subcutaneous insulin infusion or multiple daily injections. , 2009, Diabetes technology & therapeutics.

[18]  A. McCall,et al.  The Median is Not the Only Message: A Clinician's Perspective on Mathematical Analysis of Glycemic Variability and Modeling in Diabetes Mellitus , 2009, Journal of diabetes science and technology.

[19]  I. Hirsch,et al.  Should minimal blood glucose variability become the gold standard of glycemic control? , 2005, Journal of diabetes and its complications.

[20]  P. Oskarsson,et al.  Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade? , 2008, Diabetes & metabolism.

[21]  D. Rodbard,et al.  Assessing glycemic variation: why, when and how? , 2010, Pediatric endocrinology reviews : PER.

[22]  J. Wojcicki,et al.  “J”-Index. A New Proposition of the Assessment of Current Glucose Control in Diabetic Patients , 1995, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[23]  D. Rodbard,et al.  The Minimum Frequency of Glucose Measurements from Which Glycemic Variation Can Be Consistently Assessed , 2010, Journal of diabetes science and technology.

[24]  David Rodbard,et al.  Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control. , 2009, Diabetes technology & therapeutics.

[25]  Howard Zisser,et al.  Improved quality of glycemic control and reduced glycemic variability with use of continuous glucose monitoring. , 2009, Diabetes technology & therapeutics.

[26]  L. Jovanovic,et al.  Relationship of Fasting and Hourly Blood Glucose Levels to HbA1c Values , 2006, Diabetes Care.

[27]  Michael Brownlee,et al.  Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications. , 2006, JAMA.

[28]  David Rodbard,et al.  New and improved methods to characterize glycemic variability using continuous glucose monitoring. , 2009, Diabetes technology & therapeutics.

[29]  W. F. Taylor,et al.  Mean Amplitude of Glycemic Excursions, a Measure of Diabetic Instability , 1970, Diabetes.

[30]  J. Schlichtkrull,et al.  [M-VALUE, AN INDEX FOR BLOOD SUGAR CONTROL IN DIABETICS]. , 1964, Ugeskrift for laeger.

[31]  A. Rigby,et al.  Effect of Glucose Variability on the Long-Term Risk of Microvascular Complications in Type 1 Diabetes , 2009, Diabetes Care.

[32]  Christian Weber,et al.  The assessment of glycemic variability and its impact on diabetes-related complications: an overview. , 2009, Diabetes technology & therapeutics.

[33]  C. McDonnell,et al.  A novel approach to continuous glucose analysis utilizing glycemic variation. , 2005, Diabetes technology & therapeutics.

[34]  H. van Lenthe,et al.  A randomized clinical trial comparing the effect of basal insulin and inhaled mealtime insulin on glucose variability and oxidative stress , 2009, Diabetes, obesity & metabolism.

[35]  B P Kovatchev,et al.  Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index. , 1998, Diabetes care.

[36]  A. Rigby,et al.  Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes: data from the DCCT , 2009, Diabetologia.

[37]  R. Rizza,et al.  Measurements of Glucose Control , 1987, Diabetes Care.

[38]  David Rodbard,et al.  Optimizing Display, Analysis, Interpretation and Utility of Self-Monitoring of Blood Glucose (SMBG) Data for Management of Patients with Diabetes , 2007, Journal of diabetes science and technology.

[39]  I. Bross How to use Ridit Analysis , 1958 .

[40]  Boris Kovatchev,et al.  Statistical tools to analyze continuous glucose monitor data. , 2009, Diabetes technology & therapeutics.